Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report)’s stock price traded up 3.9% during mid-day trading on Friday . The stock traded as high as $6.74 and last traded at $6.74. 8,293 shares were traded during mid-day trading, a decline of 52% from the average session volume of 17,412 shares. The stock had previously closed at $6.49.
Fortress Biotech Trading Up 3.9 %
The firm has a fifty day simple moving average of $6.44 and a 200 day simple moving average of $6.08.
Fortress Biotech Company Profile
Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.
Recommended Stories
- Five stocks we like better than Fortress Biotech
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- FedEx Delivers Another Crushing Blow to Its Stock Price
- The Role Economic Reports Play in a Successful Investment Strategy
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Market Cap Calculator: How to Calculate Market Cap
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
